Researchers at the University of Hawaii Cancer Center have discovered a new set of markers to test people for the condition years in advance of receiving a type 2 diagnosis, and giving them an opportunity to modify their lifestyles and prevent the onset of diabetes.
A UCLA study shows only a small percentage of those diagnosed with prediabetes are given the first line type 2 medication. And considering its benefits for the type 2 patient population, the healthcare community and federal government may need to reconsider prescribing practices for this drug in the prediabetes patient population.
A study shows that Twitter can be a better indicator of people's overall well being and potential risk of coronary heart disease (CHD) more than other traditional health factors such as smoking and diabetes.
A large-scaled study showed that type 2 patients treated with metformin, used to control glucose levels in the body and already known to exhibit anticancer properties, can live longer than people without the condition.
According to a new position statement released at the Association's 74th Scientific Sessions, the American Diabetes Association is lowering its target recommendation for blood glucose levels for children with type 1 diabetes.
In a study that included data from more than three million children and adolescents from diverse geographic regions of the United States, researchers found that the prevalence of both type 1 and type 2 diabetes increased significantly between 2001 and 2009.